Literature DB >> 29560906

Using Neuroimaging to Decipher the Mechanism of Action of Ketamine: A Pathway to Novel Therapeutics?

Allison C Nugent1, Carlos A Zarate2.   

Abstract

Entities:  

Year:  2017        PMID： 29560906      PMCID： PMC6251409          DOI： 10.1016/j.bpsc.2017.08.006

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN： 2451-9022


× No keyword cloud information.
  10 in total

1.  Ketamine Treatment and Global Brain Connectivity in Major Depression.

Authors:  Chadi G Abdallah; Lynnette A Averill; Katherine A Collins; Paul Geha; Jaclyn Schwartz; Christopher Averill; Kaitlin E DeWilde; Edmund Wong; Alan Anticevic; Cheuk Y Tang; Dan V Iosifescu; Dennis S Charney; James W Murrough
Journal:  Neuropsychopharmacology       Date:  2016-09-08       Impact factor: 7.853

Review 2.  Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.

Authors:  Mark J Niciu; Daniel C Mathews; Allison C Nugent; Dawn F Ionescu; Maura L Furey; Erica M Richards; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2013-12-18       Impact factor: 6.505

3.  Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment.

Authors:  Chadi G Abdallah; Christopher L Averill; Ramiro Salas; Lynnette A Averill; Philip R Baldwin; John H Krystal; Sanjay J Mathew; Daniel H Mathalon
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-10

4.  Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.

Authors:  Brian R Cornwell; Giacomo Salvadore; Maura Furey; Craig A Marquardt; Nancy E Brutsche; Christian Grillon; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2012-04-21       Impact factor: 13.382

Review 5.  Human biomarkers of rapid antidepressant effects.

Authors:  Carlos A Zarate; Daniel C Mathews; Maura L Furey
Journal:  Biol Psychiatry       Date:  2013-01-29       Impact factor: 13.382

6.  Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile.

Authors:  R Joules; O M Doyle; A J Schwarz; O G O'Daly; M Brammer; S C Williams; M A Mehta
Journal:  Psychopharmacology (Berl)       Date:  2015-05-19       Impact factor: 4.530

7.  Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.

Authors:  N V Kraguljac; M A Frölich; S Tran; D M White; N Nichols; A Barton-McArdle; M A Reid; M S Bolding; A C Lahti
Journal:  Mol Psychiatry       Date:  2016-08-02       Impact factor: 15.992

8.  Towards a consensus regarding global signal regression for resting state functional connectivity MRI.

Authors:  Kevin Murphy; Michael D Fox
Journal:  Neuroimage       Date:  2016-11-22       Impact factor: 6.556

9.  Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.

Authors:  Suresh D Muthukumaraswamy; Alexander D Shaw; Laura E Jackson; Judith Hall; Rosalyn Moran; Neeraj Saxena
Journal:  J Neurosci       Date:  2015-08-19       Impact factor: 6.167

10.  NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Polymnia Georgiou; Jonathan Fischell; Greg I Elmer; Manickavasagom Alkondon; Peixiong Yuan; Heather J Pribut; Nagendra S Singh; Katina S S Dossou; Yuhong Fang; Xi-Ping Huang; Cheryl L Mayo; Irving W Wainer; Edson X Albuquerque; Scott M Thompson; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Nature       Date:  2016-05-04       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.